Catalyst Pharmaceutical CPRX Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Catalyst Pharmaceutical’s reported figures.
The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Catalyst Pharmaceutical's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Catalyst Pharmaceutical's free cash flow?
- Catalyst Pharmaceutical (CPRX) reported free cash flow of $59.56M in Q1 2026.
- How has Catalyst Pharmaceutical's free cash flow changed year-over-year?
- Catalyst Pharmaceutical's free cash flow decreased by 0.8% year-over-year, from $60.04M to $59.56M.
- What is the long-term trend for Catalyst Pharmaceutical's free cash flow?
- Over 3 years (2021 to 2025), Catalyst Pharmaceutical's free cash flow has grown at a 52.0% compound annual growth rate (CAGR), from $59.35M to $208.61M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.